Diabetes medication recalls
76 FDA-recorded recalls of diabetes medications, most recent Aug 2026 — newest first, straight from the FDA's own database.
Several extended-release metformin products were recalled for nitrosamine (NDMA) impurities — the same class of contaminant behind the blood-pressure recalls. Others are ordinary manufacturing or potency issues. Blood-sugar control matters: do not stop a diabetes medicine because of a recall without checking your specific lot against the FDA notice and speaking with your prescriber.
Exenatide Injection
Class IIDefective Delivery System: Possibility of no medication in the prefilled pen.
Amneal Pharmaceuticals of New York, LLC · Sep 30, 2026
MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1…
Class IICGMP Deviations
Baxter Healthcare Corporation · Sep 9, 2026
SEMAGLUTIDE 20mg (5mg/mL)
Class IIPresence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Apollo Care, LLC · Aug 19, 2026
SEMAGLUTIDE 2.25MG (0.9 mg/mL)
Class IIPresence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Apollo Care, LLC · Aug 19, 2026
SEMAGLUTIDE 0.9mg (0.9 mg/mL)
Class IIPresence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Apollo Care, LLC · Aug 19, 2026
SEMAGLUTIDE 10mg (5mg/mL)
Class IIPresence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Apollo Care, LLC · Aug 19, 2026
SEMAGLUTIDE 12.5MG (2.5MG/mL)
Class IIPresence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Apollo Care, LLC · Aug 19, 2026
SEMAGLUTIDE 2.5mg (1mg/mL)
Class IIPresence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Apollo Care, LLC · Aug 19, 2026
SEMAGLUTIDE 5mg (1mg/mL)
Class IIPresence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Apollo Care, LLC · Aug 19, 2026
SEMAGLUTIDE 7.5mg (5mg/mL)
Class IIPresence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Apollo Care, LLC · Aug 19, 2026
SEMAGLUTIDE 4.5mg (0.9 mg/mL)
Class IIPresence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Apollo Care, LLC · Aug 19, 2026
SEMAGLUTIDE 9mg (4.5 mg/mL)
Class IIPresence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Apollo Care, LLC · Aug 19, 2026
SEMAGLUTIDE 6.75mg (4.5 mg/mL)
Class IIPresence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Apollo Care, LLC · Aug 19, 2026
Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release
Class IICGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.
Boehringer Ingelheim Pharmaceuticals, Inc. · Jul 8, 2026
Liraglutide Injection
Class IIPresence of particulate matter: a white thread-like structure in the cartridge
Lupin Pharmaceuticals Inc. · May 27, 2026
Semaglutide-Glycine-Cyanocobalamin Injectable
Class IILack of Assurance of Sterility
PAYLESS COMPOUNDERS, LLC · Apr 22, 2026
Semaglutide Inj
Class IILack of Assurance of Sterility
New Life Pharma LLC · Mar 11, 2026
Semaglutide Inj.
Class IILack of Assurance of Sterility
New Life Pharma LLC · Mar 11, 2026
Tirzepatide Inj
Class IILack of Assurance of Sterility
New Life Pharma LLC · Mar 11, 2026
Tirzepatide Inj
Class IILack of Assurance of Sterility
New Life Pharma LLC · Mar 11, 2026
Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01…
Class IICGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
Harbin Jixianglong Biotech Co., Ltd. · Mar 11, 2026
Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01…
Class IICGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
Harbin Jixianglong Biotech Co., Ltd. · Mar 11, 2026
Wegovy (semaglutide) Injection
Class IIPresence of Particulate Matter: Hair was found in a prefilled syringe
Novo Nordisk Inc. · Jan 7, 2026
Wegovy (semaglutide) Injection
Class IIPresence of Particulate Matter: Hair was found in a prefilled syringe
Novo Nordisk Inc. · Jan 7, 2026
Semaglutide Injection
Class IILack of Assurance of Sterility
ProRx LLC · Nov 5, 2025
Semaglutide Injection
Class IILack of Assurance of Sterility
ProRx LLC · Nov 5, 2025
Semaglutide Injection
Class IILack of Assurance of Sterility
ProRx LLC · Nov 5, 2025
Semaglutide Injection
Class IILack of Assurance of Sterility
ProRx LLC · Nov 5, 2025
Semaglutide Injection
Class IILack of Assurance of Sterility
ProRx LLC · Nov 5, 2025
Tirzepatide Injection
Class IILack of Assurance of Sterility
ProRx LLC · Nov 5, 2025
Semaglutide Injection
Class IILack of Assurance of Sterility
ProRx LLC · Nov 5, 2025
Semaglutide for Injection
Class IILack of Assurance of Sterility
GenoGenix LLC · Oct 15, 2025
Semaglutide with B12 for Injection
Class IILack of Assurance of Sterility
GenoGenix LLC · Oct 15, 2025
Tirzepatide, 60mg/10 mL for Injection, 10mL vial lyophilized, all…
Class IILack of Assurance of Sterility
GenoGenix LLC · Oct 15, 2025
Tirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol
Class IILack of Processing Controls.
AEQUITA PHARMACY · Aug 13, 2025
Semaglutide + Cyanocobalamin injection solution
Class IILack of Processing Controls.
AEQUITA PHARMACY · Aug 13, 2025
Tirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol
Class IILack of Processing Controls.
AEQUITA PHARMACY · Aug 13, 2025
Semaglutide + Cyanocobalamin 0.44 mg + 0.25mg/0.5 mL Inj Sol
Class IILack of Processing Controls.
AEQUITA PHARMACY · Aug 13, 2025
Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol
Class IILack of Processing Controls.
AEQUITA PHARMACY · Aug 13, 2025
Semaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj Sol
Class IILack of Processing Controls.
AEQUITA PHARMACY · Aug 13, 2025
Tirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol
Class IILack of Processing Controls.
AEQUITA PHARMACY · Aug 13, 2025
Semaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj Sol
Class IILack of Processing Controls.
AEQUITA PHARMACY · Aug 13, 2025
Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol
Class IILack of Processing Controls.
AEQUITA PHARMACY · Aug 13, 2025
Tirzepatide + Niacinamide 6.6 mg + 1.0mg/0.5 mL Inj Sol
Class IILack of Processing Controls.
AEQUITA PHARMACY · Aug 13, 2025
Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol
Class IILack of Processing Controls.
AEQUITA PHARMACY · Aug 13, 2025
Tirzepatide + Niacinamide 8.8 mg + 1.0mg/0.5 ml Inj Sol
Class IILack of Processing Controls.
AEQUITA PHARMACY · Aug 13, 2025
Tirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj Sol
Class IILack of Processing Controls.
AEQUITA PHARMACY · Aug 13, 2025
Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy
Class IISubpotent Drug
Boothwyn Pharmacy LLC · Sep 10, 2025
Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy
Class IISubpotent Drug
Boothwyn Pharmacy LLC · Sep 10, 2025
Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy
Class IISubpotent Drug
Boothwyn Pharmacy LLC · Sep 10, 2025
Semaglutide, 5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88…
Class IILack of Assurance of Sterility
Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) · Jul 2, 2025
Tirzepatide/Cyanocobalamin Injectable
Class IILack of Assurance of Sterility
Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) · Jul 2, 2025
Tirzepatide Injections
Class IILack of Assurance of Sterility
Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) · Jul 2, 2025
Tirzepatide/Cyanocobalamin Injectable
Class IILack of Assurance of Sterility
Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) · Jul 2, 2025
Tirzepatide Injections
Class IILack of Assurance of Sterility
Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) · Jul 2, 2025
Semaglutide, 2.5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88…
Class IILack of Assurance of Sterility
Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) · Jul 2, 2025
Semaglutide/Cyanocobalamin Injectable
Class IILack of Assurance of Sterility
Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) · Jul 2, 2025
Tirzepatide Injections
Class IILack of Assurance of Sterility
Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) · Jul 2, 2025
Wegovy (semaglutide) injection
Class IITemperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.
Cardinal Health Inc. · May 7, 2025
Saxagliptin Tablets 5mg
Class IICGMP Deviations
Glenmark Pharmaceuticals Inc., USA · Apr 16, 2025
How to use this page
A drug appearing here does not mean your prescription is unsafe. Recalls name specific lots and manufacturers — open the recall to see the affected lot numbers, and match them against your bottle. Never stop a blood-pressure, cholesterol, diabetes, antidepressant or antibiotic medicine on your own because of a recall; confirm your lot, then ask your pharmacist for a replacement if it is affected.
Other categories: Blood pressure medication · Eye drop and ophthalmic · Cholesterol medication · Antidepressant · Antibiotic · Thyroid medication · Allergy and antihistamine · Hormonal and contraceptive · ADHD and stimulant medication · Opioid and pain medication · Seizure and epilepsy medication · Asthma and inhaler · Heartburn and acid-reflux medication. See also the full recalls tracker and the recall report.
Source: the openFDA drug Enforcement (recall) database. Recalls are matched to this category by the drug names in the FDA’s product description; a small number of category recalls may be missed if the description omits the ingredient. Figures are recall events, not units, and reflect our copy of the FDA data, refreshed daily. This is public regulatory data, not medical advice.